Organization
Red Cross Hospital
5 abstracts
Abstract
Multiomic factor analysis for pathologic complete response (pCR) after 12 weeks of pembrolizumab + trastuzumab + pertuzumab in HER2-enriched (HER2-E) early breast cancer (eBC) in the Keyriched-1 trial.Org: West German Study Group, Moenchengladbach, Germany, Queen Mary University of London, London, United Kingdom, Medical School Brandenburg, Institute for Biometrics and Registry Research, Neuruppin, Neuruppin, Germany,
Abstract
ANTIBODIES TO CYTOMEGALOVIRUS IN OSTEOARTHRITISOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Clinical Microbiology Laboratory, IRCCS-ASMN, Reggio Emilia, Italy, Asklepieion Hospital, Endocrinology and Metabolism Institute, Red Cross Hospital,
Abstract
ANTIBODIES TO CYTOMEGALOVIRUS IN RHEUMATOID ARTHRITISOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Clinical Microbiology Laboratory, IRCCS-ASMN, Reggio Emilia, Italy, Asklepieion Hospital, Endocrinology and Metabolism Institute, Red Cross Hospital,
Abstract
ANTIBODIES TO PARVOVIRUS B19 IN SYSTEMIC LUPUS ERYTHEMATOSUSOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Clinical Microbiology Laboratory, IRCCS-ASMN, Reggio Emilia, Italy, Asklepieion Hospital, Endocrinology and Metabolism Institute, Red Cross Hospital,
Abstract
ANTIBODIES TO PARVOVIRUS B19 IN PSORIATIC ARTHRITISOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Clinical Microbiology Laboratory, IRCCS-ASMN, Reggio Emilia, Italy, Asklepieion Hospital, Endocrinology and Metabolism Institute, Red Cross Hospital,